Delving into the Latest Updates on Accuredit Therapeutics (Suzhou) Co., Ltd. with Synapse

Overview

Tags

Endocrinology and Metabolic Disease

Cardiovascular Diseases

Other Diseases

Gene editing

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	4

Top 5 Drug Type	Count

Gene editing	5

Top 5 Target	Count

TTR(Transthyretin)	1

Primary objective: To evaluate the safety and tolerability of ART001 injection in subjects with transthyretin amyloidosis polyneuropathy (ATTR-PN); Secondary objective: To evaluate the pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity and efficacy of ART001 injection in subjects with ATTR-PN.

Start Date-

Sponsor / Collaborator

Accuredit Therapeutics (Suzhou) Co., Ltd.

CTR20243298 / Not yet recruitingPhase 1/2

ART001注射液治疗转甲状腺素蛋白淀粉样变性心肌病的多中心、开放、单臂I/IIa期临床研究

[Translation] A multicenter, open, single-arm phase I/IIa clinical study of ART001 injection in the treatment of transthyretin amyloid cardiomyopathy

1、主要目的：评估ART001注射液在转甲状腺素蛋白淀粉样变性心肌病（ATTR-CM）受试者中的安全性和耐受性； 2、次要目的：评估ART001注射液在ATTR-CM受试者中的药代动力学（PK）、药效动力学（PD）、免疫原性和疗效。

[Translation]

1. Primary objective: To evaluate the safety and tolerability of ART001 injection in subjects with transthyretin amyloid cardiomyopathy (ATTR-CM); 2. Secondary objective: To evaluate the pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity and efficacy of ART001 injection in subjects with ATTR-CM.

Start Date-

Sponsor / Collaborator

Accuredit Therapeutics (Suzhou) Co., Ltd.

100 Clinical Results associated with Accuredit Therapeutics (Suzhou) Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Accuredit Therapeutics (Suzhou) Co., Ltd.

Login to view more data

100 Deals associated with Accuredit Therapeutics (Suzhou) Co., Ltd.

Login to view more data

100 Translational Medicine associated with Accuredit Therapeutics (Suzhou) Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

4

1

Phase 2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

ART-001(Accuredit) ( TTR )	Transthyretin-mediated amyloidosis More	IND Approval
ART009	Metabolic Diseases More	Preclinical
ART003	Genetic Diseases, Inborn More	Preclinical
ART002(Accuredit)	Metabolic Diseases More	Preclinical
ART010(AccurEdit Therapeutics)	Metabolic Diseases More	Preclinical